AbsEn.i
Curation
Istex
Racine
Curation
Checkpoint
Istex
Racine
Istex
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « those »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
thoroughly < those < though  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 42.
[0-20] [0 - 20][0 - 42][20-40]
Ident.Authors (with country if any)Title
000030 (2010) Katja Perdan-Pirkmajer [Slovénie] ; Sonja Praprotnik [Slovénie] ; Matija Tomši [Slovénie]A case of refractory adult-onset Still’s disease successfully controlled with tocilizumab and a review of the literature
000048 (2012) Hiroki Wakabayashi [Japon] ; Masahiro Hasegawa [Japon] ; Yosuke Nishioka [Japon] ; Yukari Minami [Japon] ; Kusuki Nishioka [Japon] ; Akihiro Sudo [Japon]Clinical outcome in patients with rheumatoid arthritis switched to tocilizumab after etanercept or infliximab failure
000066 (2013) Kanae Tani [Japon] ; Risa Takayanagi [Japon] ; Haruko Yokoyama [Japon] ; Yasuhiko Yamada [Japon]Theoretical analysis of efficacy of biological agent for rheumatoid arthritis based on target molecular binding occupancy
000091 (2012) Sooha Kim [Royaume-Uni] ; Andrew J. K. Östör [Royaume-Uni] ; Muhammad K. Nisar [Royaume-Uni]Interleukin-6 and cytochrome-P450, reason for concern?
000102 (2011) Masahiko Suzuki [Japon] ; Keiichiro Nishida [Japon] ; Satoshi Soen [Japon] ; Hiromi Oda [Japon] ; Hiroshi Inoue [Japon] ; Atsushi Kaneko [Japon] ; Kenji Takagishi [Japon] ; Takaaki Tanaka [Japon] ; Tsukasa Matsubara [Japon] ; Naoto Mitsugi [Japon] ; Yuichi Mochida [Japon] ; Shigeki Momohara [Japon] ; Toshihito Mori [Japon] ; Toru Suguro [Japon]Risk of postoperative complications in rheumatoid arthritis relevant to treatment with biologic agents: a report from the Committee on Arthritis of the Japanese Orthopaedic Association
000133 (2009) Shin-Ya Kawashiri [Japon] ; Atsushi Kawakami [Japon] ; Satoshi Yamasaki [Japon] ; Takahiro Imazato [Japon] ; Naoki Iwamoto [Japon] ; Keita Fujikawa [Japon] ; Toshiyuki Aramaki [Japon] ; Mami Tamai [Japon] ; Hideki Nakamura [Japon] ; Hiroaki Ida [Japon] ; Tomoki Origuchi [Japon] ; Yukitaka Ueki [Japon] ; Katsumi Eguchi [Japon]Effects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritis
000189 (2013) Diogo Mendes [Portugal] ; Carlos Alves [Portugal] ; Francisco Batel Marques [Portugal]Safety of biologics approved for treating rheumatoid arthritis: analysis of spontaneous reports of adverse events
000204 (2010) C. J. Edwards [Royaume-Uni] ; E. Williams [Royaume-Uni]The role of interleukin-6 in rheumatoid arthritis-associated osteoporosis
000228 (2012) Tomoyuki Imagawa [Japon] ; Syuji Takei [Japon] ; Hiroaki Umebayashi [Japon] ; Kenichi Yamaguchi [Japon] ; Yasuhiko Itoh [Japon] ; Toshinao Kawai [Japon] ; Naomi Iwata [Japon] ; Takuji Murata [Japon] ; Ikuo Okafuji [Japon] ; Mari Miyoshi [Japon] ; Yasuhiro Onoe [Japon] ; Yoshifumi Kawano [Japon] ; Noriko Kinjo [Japon] ; Masaaki Mori [Japon] ; Neelufar Mozaffarian [États-Unis] ; Hartmut Kupper [Allemagne] ; Sourav Santra [Inde] ; Gina Patel [États-Unis] ; Shinichi Kawai [Japon] ; Shumpei Yokota [Japon]Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan
000241 (2010) Tamotsu Kamishima [Japon] ; Kazuhide Tanimura [Japon] ; Yuko Aoki [Japon] ; Naoki Kosaka [Japon] ; Masato Shimizu [Japon] ; Megumi Matsuhashi [Japon] ; Jun Fukae [Japon] ; Yujiro Kon [Royaume-Uni] ; Satoshi Terae [Japon] ; Hiroki Shirato [Japon]Simplified approach to MR image quantification of the rheumatoid wrist: a pilot study
000251 (2006) Chi Chiu Mok [Hong Kong]Biological therapies for rheumatoid arthritis: beyond TNF‐α blockade
000256 (2012) Tsuyoshi Kasama [Japon] ; Hidekazu Furuya [Japon] ; Ryo Yanai [Japon] ; Kumiko Ohtsuka [Japon] ; Ryo Takahashi [Japon] ; Nobuyuki Yajima [Japon] ; Yusuke Miwa [Japon] ; Kazuo Kobayashi [Japon]Correlation of serum CX3CL1 level with disease activity in adult-onset Still's disease and significant involvement in hemophagocytic syndrome
000294 (2013) Shunsei Hirohata [Japon] ; Tetsuya Tomita [Japon] ; Hideki Yoshikawa [Japon] ; Masahisa Kyogoku [Japon]TNF inhibitors induce discoid fibrosis in the sublining layers of the synovium with degeneration of synoviocytes in rheumatoid arthritis
000300 (2012) Joerg-Patrick Stübgen [États-Unis]Targeted immunotherapy trials for idiopathic inflammatory myopathies
000304 (2013) Tomokazu Nagao ; Reina Kusunoki ; Chiaki Iwamura ; Shigeto Kobayashi ; Wako Yumura ; Yosuke Kameoka [Japon] ; Toshinori Nakayama ; Kazuo Suzuki [Japon]Correlation of interleukin‐6 and monocyte chemotactic protein‐1 concentrations with crescent formation and myeloperoxidase‐specific anti‐neutrophil cytoplasmic antibody titer in SCG/Kj mice by treatment with anti‐interleukin‐6 receptor antibody or mizoribine
000306 (2013) Pavel Horák [République tchèque] ; Martina Skácelová [République tchèque] ; Karel Hejduk [République tchèque] ; Andrea Smržová [République tchèque] ; Karel Pavelka [République tchèque]Abatacept and its use in the treatment of rheumatoid arthritis (RA) in the Czech Republic—data from the ATTRA registry
000308 (2013) M. Vis [Pays-Bas] ; M. Güler-Yüksel [Pays-Bas] ; W. F. Lems [Pays-Bas]Can bone loss in rheumatoid arthritis be prevented?
000510 (2013) H. Pieringer [Autriche] ; U. C. Hoppe [Autriche]Warum die rheumatoide Arthritis den Kardiologen braucht
000674 (2013) Christoph Fiehn [Allemagne] ; Elisabeth Belke-Voss [Allemagne] ; Dietmar Krause [Allemagne] ; Siegfried Wassenberg [Allemagne] ; Rolf Rau [Allemagne]Improved radiological outcome of rheumatoid arthritis: the importance of early treatment with methotrexate in the era of biological drugs
000773 (2013) Zoltán Szekanecz [Hongrie] ; Bertalan Mesk [Hongrie] ; Szilard Poliska [Hongrie] ; Andrea Váncsa [Hongrie] ; Szilvia Szamosi [Hongrie] ; Edit Végh [Hongrie] ; Enikö Simkovics [Hongrie] ; Judit Laki [Hongrie] ; Júlia Kurk [Hongrie, États-Unis] ; Timea Besenyei [Hongrie, États-Unis] ; Katalin Mikecz [États-Unis] ; Tibor T. Glant [États-Unis] ; Lászl Nagy [Hongrie]Pharmacogenetics and pharmacogenomics in rheumatology
000829 (2013) K. Michaud ; S. Pedro ; T. Simon [États-Unis] ; F. WolfeFRI0250 Are rheumatoid arthritis patients who receive abatacept comparable with those on other biologics?

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "those" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "those" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    those
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021